Top

Reactions Weekly

Published in:

01-05-2023 | Multiple Sclerosis | Case report

Interferon-beta

Thrombotic microangiopathy and complement factor I deficiency: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Mrabet S, et al. Thrombotic microangiopathy due to acquired complement factor I deficiency in a male receiving interferon-beta treatment for multiple sclerosis. British Journal of Clinical Pharmacology 89 : 1682-1685, No. 5, May 2023. Available from: URL: http://doi.org/10.1111/bcp.15631 [Summarised from an abstract]

Title: Interferon-beta
Thrombotic microangiopathy and complement factor I deficiency: case report
Publication date: 01-05-2023
Publisher: Springer International Publishing
Keywords: Multiple Sclerosis
Thrombotic Microangiopathy
Hemolytic Anemia
Interferon
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-38458-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Interferon-beta

Thrombotic microangiopathy and complement factor I deficiency: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Dexamethasone/remdesivir

Cisplatin

Methylprednisolone/tacrolimus

Bevacizumab/gefitinib

Multiple drugs

Methylprednisolone/prednisone/valganciclovir